David Young

Title: David Young: Innovator in Pharmaceutical Treatments

Introduction

David Young is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of acute respiratory distress syndrome. With a total of 3 patents to his name, Young's work exemplifies innovation in medical science.

Latest Patents

One of David Young's latest patents focuses on the use of adrenocorticotropic hormone (ACTH) for the treatment of acute respiratory distress syndrome. This patent outlines methods of treatment that involve administering ACTH or its derivatives to individuals in need. Another significant patent is a tool for in vitro-in vivo correlation, which describes a biological modeling system and method for enhanced computer-aided analysis of biological response data. This innovative approach synthesizes information from both immediate and extended release in vivo data and in vitro data, ultimately improving the predictability of drug absorption profiles.

Career Highlights

Throughout his career, David Young has worked with prominent companies in the pharmaceutical industry, including Questcor Pharmaceuticals, Inc. and Mallinckrodt Ard IP Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development and treatment methodologies.

Collaborations

David Young has collaborated with several professionals in his field, including Laura S. Lehman and David Tierney. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

David Young's contributions to pharmaceutical innovations, particularly in the treatment of acute respiratory distress syndrome, highlight his role as a significant inventor in the medical field. His patents and collaborations reflect a commitment to advancing healthcare solutions.